Project Number CAF-HOLTZMAN-2013 Agency/Funding Organization Cure Alzheimer's Fund Funding Year 2013 View Full Project Details for Sleep and tauopathies: Effect of an anti-tau antibody. Research Categorization Primary Disease / Condition Alzheimer's Disease Frontotemporal Dementia CADRO Category C. Translational Research and Clinical Interventions 3. Drug Discovery (small molecules and biologics) b. Tau Researcher and Organization Principal Investigator HOLTZMAN, DAVID M Principal Investigator First Name DAVID Principal Investigator Last Name HOLTZMAN Awardee Organization WASHINGTON UNIVERSITY IN SAINT LOUIS Awardee State Missouri Contact PI Country United States Project Detail FY Overall Cost $100,000 Funding Organization Agency/Funding Organization Cure Alzheimer's Fund Funding Organization Country United States
